EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Survival outcomes and prognostic factors in children and adults with medulloblastoma from a Latin America country: A retrospective cohort

Michael Mallouh iD, Gabriel De la Cruz-Ku iD, Renato Luque-Benavides iD, Bryan Valcarcel, Flavia Rioja, Martin Hemeryth, J Smith Torres-Roman, Diego Chambergo-Michilot, Juan Haro Varas, Daniel Enriquez-Vera, Jhajaira M Araujo iD, Rosdali Diaz-Coronado und 1 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0333611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Michael Mallouh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Medulloblastoma, Cerebellar Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Few studies have evaluated the real-world outcomes of patients with medulloblastoma with contradictory results. Therefore, we aimed to compare the characteristics, survival outcomes, and prognostic factors between children and adults with medulloblastoma.

Methods

We conducted a retrospective cohort study in a single academic center between 2000 and 2016. Patients were categorized into children and adolescents (≤19 years) and adults (>19 years). Overall survival (OS) and disease-free survival (DFS) were estimated with the Kaplan-Meier method. Prognostic factors were determined using Cox models.

Results

In total, 173 patients were included (79 adults and 94 children). No differences were observed in clinical characteristics according to age groups. At 5 years, DFS was 36.88% in children and 50.99% in adults (p = 0.476). Prognostic factors of DFS in adults were radiotherapy (adjusted Hazard ratio [aHR]: 0.22; 95% confidence interval [CI]: 0.07–0.67) and performance status 2–4 (aHR: 3.60; 95% CI: 1.48–8.77); while in children was radiotherapy (aHR: 0.33; 95% CI: 0.11–0.96) and chemotherapy (aHR: 0.34; 95% CI: 0.14–0.84). The 5-year OS rate was 64.25% in children and 60.87% in adults (p = 0.447). In adults, prognostic factors of OS were histologic type (aHR: 6.11, 95% CI: 1.19–31.48, for anaplastic) and radiotherapy (aHR: 0.22, 95% CI: 0.07–0.71), while in children and adolescents, lower performance status (aHR: 2.43, 95% CI: 1.09–5.39, for performance status 2–4) was the only prognostic factor. Subgroup analyses revealed a trend toward improved DFS and significantly better OS among adults who completed chemotherapy, highlighting the importance of treatment adherence.

Conclusions

Both populations demonstrated similar survival rates that were comparable to or lower than those reported in previous studies. In adults, performance status and radiotherapy were prognostic factors for DFS, while histologic type and radiotherapy for OS. In children, chemotherapy and radiotherapy were prognostic factors for DFS, and performance status was the only OS prognostic factor. These findings underscore the importance of optimizing treatment adherence and completing standard therapies, as well as improving staging practices, to enhance outcomes in real-world settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedulloblastomaCerebellar NeoplasmsHumansAdolescentFemaleMaleAdultRetrospective StudiesChildPrognosisChild, PreschoolYoung AdultMiddle AgedDisease-Free SurvivalLatin AmericaKaplan-Meier Estimate

Autor:innen und Institutionen

  • Department of Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
  • Universidad Cientifica del Sur, Lima, Perú.
  • George Washington University, Washington, DC, United States of America.
  • Escuela de Postgrado, Universidad Tecnológica del Perú, Lima, Peru.
  • Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru.

ORCID-Profile: Michael Mallouh, Gabriel De la Cruz-Ku, Renato Luque-Benavides, Jhajaira M Araujo, Victor Castro Oliden

Zitieren

APA

Mallouh, M., De la Cruz-Ku, G., Luque-Benavides, R., Valcarcel, B., Rioja, F., Hemeryth, M., Torres-Roman, J. S., Chambergo-Michilot, D., Varas, J. H., Enriquez-Vera, D., Araujo, J. M., Diaz-Coronado, R., & Castro Oliden, V. (2025). Survival outcomes and prognostic factors in children and adults with medulloblastoma from a Latin America country: A retrospective cohort. PLOS One. https://doi.org/10.1371/journal.pone.0333611

Vancouver

Mallouh M, De la Cruz-Ku G, Luque-Benavides R, Valcarcel B, Rioja F, Hemeryth M, et al. Survival outcomes and prognostic factors in children and adults with medulloblastoma from a Latin America country: A retrospective cohort. PLOS One. 2025. doi:10.1371/journal.pone.0333611

BibTeX
@article{Mallouh2025,
  author = {Mallouh, Michael and De la Cruz-Ku, Gabriel and Luque-Benavides, Renato and Valcarcel, Bryan and Rioja, Flavia and Hemeryth, Martin and Torres-Roman, J Smith and Chambergo-Michilot, Diego and Varas, Juan Haro and Enriquez-Vera, Daniel and Araujo, Jhajaira M and Diaz-Coronado, Rosdali and Castro Oliden, Victor},
  title = {Survival outcomes and prognostic factors in children and adults with medulloblastoma from a Latin America country: A retrospective cohort},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0333611}
}
Kostenlos starten →